anti pd l1 antibody (Bio X Cell)
Bio X Cell is a verified supplier 
Bio X Cell manufactures this product 
96
Structured Review
Bio X Cell
anti pd l1 antibody
Anti Pd L1 Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 179 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/invivoplus+anti-mouse+cd4/InVivoPlus+anti-mouse+CD4/pm41935049-315-11-13
Average 96 stars, based on 179 article reviews
Anti Pd L1 Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 179 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/invivoplus+anti-mouse+cd4/InVivoPlus+anti-mouse+CD4/pm41935049-315-11-13
Average 96 stars, based on 179 article reviews
anti pd l1 antibody - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Control:Article Title: PPP2R2A insufficiency enhances PD-L1 immune checkpoint blockade efficacy in lung cancer through cGAS-STING activation. Article Snippet: Samples were analyzed immediately on Cytek Aurora, 15 and data analysis was performed using FlowJo (Tree Star) or OMIQ software 16 (https://www.omiq.ai/). .. After nine 19 days, mice were randomized to control (Rat IgG2b In Vivo Isotype Control, 100 μg/dose, 20 Cat:ICH2243, Clone: 1-2, Ichorbio), α-PD-L1 alone (Anti-Mouse PD-L1 In Vivo Antibody, 100 21 μg/dose, Cat:ICH1086, Clone:10F.9G2, Ichorbio), Article Title: Biomimetic vesicles engineered from modified tumour cells act as personalized vaccines for post-surgical cancer immunotherapy. Article Snippet: .. T cell depletion experiments: to assess the role of T lymphocyte subsets, mice were injected intraperitoneally with Article Title: PPP2R2A insufficiency enhances PD-L1 immune checkpoint blockade efficacy in lung cancer through cGAS-STING activation Article Snippet: For intracellular staining, a Foxp3/Transcription Factor Staining Buffer Set (00-5523-00, eBioscience) was used according to the manufacturer’s protocol. .. After 9 days, mice were randomized to 1 of the following treatment groups: control (rat IgG2b in vivo isotype control, 100 μg/dose; ICH2243, clone 1-2, Ichorbio); α-PD-L1 alone (anti-mouse PD-L1 in vivo antibody, 100 μg/dose; ICH1086, clone 10F.9G2, Ichorbio), Article Title: A Bioorthogonal and Programmable Bacterial Delivery System for Spatiotemporally Targeted Therapy of Solid Tumors Article Snippet: .. To consume CD8+ or CD4+ T cells, 250 mg InVivoMAb anti-mouse CD8 α (BP00041, BioXCell), Article Title: Biomimetic vesicles engineered from modified tumour cells act as personalized vaccines for post-surgical cancer immunotherapy Article Snippet: .. T cell depletion experiments: to assess the role of T lymphocyte subsets, mice were injected intraperitoneally with In Vivo:Article Title: PPP2R2A insufficiency enhances PD-L1 immune checkpoint blockade efficacy in lung cancer through cGAS-STING activation. Article Snippet: Samples were analyzed immediately on Cytek Aurora, 15 and data analysis was performed using FlowJo (Tree Star) or OMIQ software 16 (https://www.omiq.ai/). .. After nine 19 days, mice were randomized to control (Rat IgG2b In Vivo Isotype Control, 100 μg/dose, 20 Cat:ICH2243, Clone: 1-2, Ichorbio), α-PD-L1 alone (Anti-Mouse PD-L1 In Vivo Antibody, 100 21 μg/dose, Cat:ICH1086, Clone:10F.9G2, Ichorbio), Article Title: PPP2R2A insufficiency enhances PD-L1 immune checkpoint blockade efficacy in lung cancer through cGAS-STING activation Article Snippet: For intracellular staining, a Foxp3/Transcription Factor Staining Buffer Set (00-5523-00, eBioscience) was used according to the manufacturer’s protocol. .. After 9 days, mice were randomized to 1 of the following treatment groups: control (rat IgG2b in vivo isotype control, 100 μg/dose; ICH2243, clone 1-2, Ichorbio); α-PD-L1 alone (anti-mouse PD-L1 in vivo antibody, 100 μg/dose; ICH1086, clone 10F.9G2, Ichorbio), Injection:Article Title: Biomimetic vesicles engineered from modified tumour cells act as personalized vaccines for post-surgical cancer immunotherapy. Article Snippet: .. T cell depletion experiments: to assess the role of T lymphocyte subsets, mice were injected intraperitoneally with Article Title: A Bioorthogonal and Programmable Bacterial Delivery System for Spatiotemporally Targeted Therapy of Solid Tumors Article Snippet: .. To consume CD8+ or CD4+ T cells, 250 mg InVivoMAb anti-mouse CD8 α (BP00041, BioXCell), Article Title: Biomimetic vesicles engineered from modified tumour cells act as personalized vaccines for post-surgical cancer immunotherapy Article Snippet: .. T cell depletion experiments: to assess the role of T lymphocyte subsets, mice were injected intraperitoneally with other:Article Title: Inhibition of circulating glycocholic acid-regulated signaling potentiates immune checkpoint therapy in colorectal cancer. Article Snippet: For antiPD-L1 antibody treatment, mice were treated with 10mg/kg or 100mg/kg Article Title: PPP2R2A insufficiency enhances PD-L1 immune checkpoint blockade efficacy in lung cancer through cGAS-STING activation Article Snippet: Samples were analyzed immediately on Cytek Aurora, 15 and data analysis was performed using FlowJo (Tree Star) or OMIQ software 16 (https://www.omiq.ai/). |